Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Introduction Kapitel lesen Erstes Kapitel lesen

2015 | OriginalPaper | Buchkapitel

9. Nanomedicine: Implications from Nanotoxicity

verfasst von : Ruhong Zhou

Erschienen in: Modeling of Nanotoxicity

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Feynman’s 1959 vision of a “smaller world” is now actively being realized through advances in nanotechnology and nanoscience [1]. Particularly over the past decade, nanotechnology has emerged as a nexus of physical and medical scientific research.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Quantum Dots and Their Ligand Passivation
Literatur
1.
Feynman RP (1960) There’s plenty of room at the bottom. Eng Sci 23(5):22–36
2.
National Science and Technology Council (2012) The national nanotechnology initiative—supplement to the president’s 2013 budget
3.
4.
Lammers T, Aime S, Hennink WE, Storm G, Kiessling F (2011) Theranostic nanomedicine. Acc Chem Res 44(10):1029–1038CrossRef
5.
Mendes RG, Bachmatiuk A, Buchner B, Cuniberti G, Rummeli MH (2013) Carbon nanostructures as multi-functional drug delivery platforms. J Mater Chem B 1(4):401–428CrossRef
6.
Kang SG, Zhou G, Yang P, Liu Y, Sun B et al (2012) Molecular mechanism of pancreatic tumor metastasis inhibition by gd@c82(oh)22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U.S.A. 109(38):15431–15436CrossRef
7.
Tu Y, Lv M, Xiu P, Huynh T, Zhang M et al (2013) Destructive extraction of phospholipids from escherichia coli membranes by graphene nanosheets. Nat Nanotechnol 8(8):594–601CrossRef
8.
Li H, Li Y, Jiao J, Hu HM (2011) Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol 6(10):645–650CrossRef
9.
Zhang Y, Zheng F, Yang T, Zhou W, Liu Y et al (2012) Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides. Nat Mater 11(9):817–826CrossRef
10.
Doane TL, Burda C (2012) The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 41(7):2885–2911CrossRef
11.
Yoo D, Lee JH, Shin TH, Cheon J (2011) Theranostic magnetic nanoparticles. Acc Chem Res 44(10):863–874CrossRef
12.
Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA et al (1998) Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of aids-related kaposi’s sarcoma: Results of a randomized phase iii clinical trial. J Clin Oncol Off J Am Soc Clin Oncol 16(7):2445–2451
13.
Safra T, Muggia F, Jeffers S, Tsao-Wei DD, Groshen S et al (2000) Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol Off J Eur Soc Med Oncol/ESMO 11(8):1029–1033CrossRef
14.
Gradishar WJ (2006) Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7(8):1041–1053CrossRef
15.
Yoo J-W, Irvine DJ, Discher DE, Mitragotri S (2011) Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 10(7):521–535CrossRef
16.
Cabral H, Nishiyama N, Kataoka K (2011) Supramolecular nanodevices: from design validation to theranostic nanomedicine. Accounts Chem Res 44(10):999–1008CrossRef
17.
18.
Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653–664CrossRef
19.
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387–6392
20.
Maeda H, Matsumura Y (2011) Epr effect based drug design and clinical outlook for enhanced cancer chemotherapy. Adv Drug Deliv Rev 63(3):129–130CrossRef
21.
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257CrossRef
22.
Kaminski MS, Tuck M, Estes J, Kolstad A, Ross CW et al (2005) 131i-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 352(5):441–449CrossRef
23.
Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11):1649–1659CrossRef
24.
Jain RK, Lee JJ, Hong D, Markman M, Gong J et al (2010) Phase i oncology studies: Evidence that in the era of targeted therapies patients on lower doses do not fare worse. Clin Cancer Res Off J Am Assoc Cancer Res 16(4):1289–1297CrossRef
25.
Cha C, Shin SR, Annabi N, Dokmeci MR, Khademhosseini A (2013) Carbon-based nanomaterials: Multifunctional materials for biomedical engineering. ACS Nano 7(4):2891–2897CrossRef
26.
Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z et al (2007) Medicinal applications of fullerenes. Int J Nanomed 2(4):639–649
27.
Anilkumar P, Lu F, Cao L, Luo PG, Liu JH et al (2011) Fullerenes for applications in biology and medicine. Curr Med Chem 18(14):2045–2059CrossRef
28.
Chawla P, Chawla V, Maheshwari R, Saraf SA, Saraf SK (2010) Fullerenes: from carbon to nanomedicine. Mini-Rev Med Chem 10(8):662–677CrossRef
29.
Cai X, Jia H, Liu Z, Hou B, Luo C et al (2008) Polyhydroxylated fullerene derivative c(60)(oh)(24) prevents mitochondrial dysfunction and oxidative damage in an mpp(+)-induced cellular model of parkinson’s disease. J Neurosci Res 86(16):3622–3634CrossRef
30.
Bogdanovic V, Stankov K, Icevic I, Zikic D, Nikolic A et al (2008) Fullerenol c60(oh)24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line. J Radiat Res 49(3):321–327CrossRef
31.
Ashcroft JM, Tsyboulski DA, Hartman KB, Zakharian TY, Marks JW et al (2006) Fullerene (c60) immunoconjugates: interaction of water-soluble c60 derivatives with the murine anti-gp240 melanoma antibody. Chem Commun (Camb) 28:3004–3006CrossRef
32.
Lu X, Feng L, Akasaka T, Nagase S (2012) Current status and future developments of endohedral metallofullerenes. Chem Soc Rev 41(23):7723–7760CrossRef
33.
Kato H, Kanazawa Y, Okumura M, Taninaka A, Yokawa T et al (2003) Lanthanoid endohedral metallofullerenols for mri contrast agents. J Am Chem Soc 125(14):4391–4397CrossRef
34.
Mikawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y et al (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for mri contrast agents. Bioconjug Chem 12(4):510–514CrossRef
35.
Chen C, Xing G, Wang J, Zhao Y, Li B et al (2005) Multihydroxylated [gd@c82(oh)22]n nanoparticles: Antineoplastic activity of high efficiency and low toxicity. Nano Lett 5(10):2050–2057CrossRef
36.
Meng H, Xing G, Blanco E, Song Y, Zhao L et al (2012) Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: Imprisoning instead of poisoning cancer cells. Nanomedicine 8(2):136–146CrossRef
37.
Yin JJ, Lao F, Meng J, Fu PP, Zhao Y et al (2008) Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol 74(4):1132–1140CrossRef
38.
Meng H, Xing G, Sun B, Zhao F, Lei H et al (2010) Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano 4(5):2773–2783CrossRef
39.
Yang D, Zhao Y, Guo H, Li Y, Tewary P et al (2010) [gd@c82(oh)22]n nanoparticles induce dendritic cell maturation and activate th1 immune responses. ACS Nano 4(2):1178–1186CrossRef
40.
Zuo G, Huang Q, Wei G, Zhou R, Fang H (2010) Plugging into proteins: poisoning protein function by a hydrophobic nanoparticle. ACS Nano 4(12):7508–7514CrossRef
41.
Ge C, Du J, Zhao L, Wang L, Liu Y et al (2011) Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U.S.A. 108(41):16968–16973CrossRef
42.
Zuo G, Zhou X, Huang Q, Fang HP, Zhou RH (2011) Adsorption of villin headpiece onto graphene, carbon nanotube, and c60: Effect of contacting surface curvatures on binding affinity. J Phys Chem C 115(47):23323–23328CrossRef
43.
Jacobsen JA, Major Jourden JL, Miller MT, Cohen SM (2010) To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta 1803(1):72–94
44.
Zhao Y, Xing G, Chai Z (2008) Nanotoxicology: are carbon nanotubes safe? Nat Nanotechnol 3(4):191–192CrossRef
45.
Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311(5761):622–627CrossRef
46.
Wong-Ekkabut J, Baoukina S, Triampo W, Tang IM, Tieleman DP et al (2008) Computer simulation study of fullerene translocation through lipid membranes. Nat Nanotechnol 3(6):363–368CrossRef
47.
Qiao R, Roberts AP, Mount AS, Klaine SJ, Ke PC (2007) Translocation of c60 and its derivatives across a lipid bilayer. Nano Lett 7(3):614–619CrossRef
48.
Shi X, von dem Bussche A, Hurt RH, Kane AB, Gao H (2011) Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat Nanotechnol 6:714–719CrossRef
49.
Wallace EJ, Sansom MSP (2008) Blocking of carbon nanotube based nanoinjectors by lipids: a simulation study. Nano Lett 8(9):2751–2756CrossRef
50.
Zhang Y, Ali SF, Dervishi E, Xu Y, Li Z et al (2010) Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived pc12 cells. ACS Nano 4(6):3181–3186CrossRef
51.
Yang K, Ma YQ (2010) Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat Nanotechnol 5(8):579–583CrossRef
52.
Vácha R, Martinez-Veracoechea FJ, Frenkel D (2011) Receptor-mediated endocytosis of nanoparticles of various shapes. Nano Lett 11(12):5391–5395CrossRef
53.
Hu W, Peng C, Luo W, Lv M, Li X et al (2010) Graphene-based antibacterial paper. ACS Nano 4(7):4317–4323CrossRef
54.
Akhavan O, Ghaderi E (2010) Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 4(10):5731–5736CrossRef
55.
Liu S, Zeng TH, Hofmann M, Burcombe E, Wei J et al (2011) Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 5(9):6971–6980CrossRef
56.
Krishnamoorthy K, Veerapandian M, Zhang L-H, Yun K, Kim SJ (2012) Antibacterial efficiency of graphene nanosheets against pathogenic bacteria via lipid peroxidation. J Phys Chem C 116(32):17280–17287CrossRef
57.
Hu W, Peng C, Lv M, Li X, Zhang Y et al (2011) Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5(5):3693–3700CrossRef
58.
Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–902CrossRef
59.
Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3):145–150CrossRef
60.
Lerf A, He H, Forster M, Klinowski J (1998) Structure of graphite oxide revisited. J Phys Chem B 102(23):4477–4482CrossRef
61.
Shih CJ, Lin S, Sharma R, Strano MS, Blankschtein D (2012) Understanding the ph-dependent behavior of graphene oxide aqueous solutions: a comparative experimental and molecular dynamics simulation study. Langmuir 28(1):235–241CrossRef
62.
Medhekar NV, Ramasubramaniam A, Ruoff RS, Shenoy VB (2010) Hydrogen bond networks in graphene oxide composite paper: Structure and mechanical properties. ACS Nano 4(4):2300–2306CrossRef
63.
Zhao J, Deng B, Lv M, Li J, Zhang Y et al (2013) Graphene oxide-based antibacterial cotton fabrics. Adv Healthc Mater 2013 (in press)
64.
Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358(9276):135–138CrossRef
65.
Wei C, Lin WY, Zainal Z, Williams NE, Zhu K et al (1994) Bactericidal activity of tio2 photocatalyst in aqueous media: Toward a solar-assisted water disinfection system. Environ Sci Technol 28(5):934–938CrossRef
66.
Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW et al (2006) Cellular toxicity of carbon-based nanomaterials. Nano Lett 6(6):1121–1125CrossRef
67.
Schipper ML, Nakayama-Ratchford N, Davis CR, Kam NW, Chu P et al (2008) A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 3(4):216–221CrossRef
68.
Yu L, Lu Y, Man N, Yu SH, Wen LP (2009) Rare earth oxide nanocrystals induce autophagy in hela cells. Small 5(24):2784–2787CrossRef
69.
Zhang Q, Yang W, Man N, Zheng F, Shen Y et al (2009) Autophagy-mediated chemosensitization in cancer cells by fullerene c60 nanocrystal. Autophagy 5(8):1107–1117CrossRef
70.
Zhang Y, Yu C, Huang G, Wang C, Wen L (2010) Nano rare-earth oxides induced size-dependent vacuolization: an independent pathway from autophagy. Int J Nanomed 5:601–609CrossRef
71.
Wu YN, Yang LX, Shi XY, Li IC, Biazik JM et al (2011) The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. Biomaterials 32(20):4565–4573CrossRef
72.
Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R et al (2012) Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 41(7):2943–2970CrossRef
73.
Kundu M, Thompson CB (2008) Autophagy: basic principles and relevance to disease. Annual Rev Pathol 3:427–455CrossRef
74.
Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27–42CrossRef
75.
Zabirnyk O, Yezhelyev M, Seleverstov O (2007) Nanoparticles as a novel class of autophagy activators. Autophagy 3(3):278–281CrossRef
76.
Heath WR, Carbone FR (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47–64CrossRef
77.
Burgdorf S, Kurts C (2008) Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 20(1):89–95CrossRef
78.
Vyas JM, Van der Veen AG, Ploegh HL (2008) The known unknowns of antigen processing and presentation. Nat Rev Immunol 8(8):607–618CrossRef
79.
Guy B (2007) The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5(7):505–517CrossRef
80.
Marrack P, McKee AS, Munks MW (2009) Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 9(4):287–293CrossRef
81.
Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776(1):86–107
82.
Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6(7):535–545CrossRef
83.
Biju V, Itoh T, Anas A, Sujith A, Ishikawa M (2008) Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications. Anal Bioanal Chem 391(7):2469–2495CrossRef
84.
Chen JY, Lee YM, Zhao D, Mak NK, Wong RN et al (2010) Quantum dot-mediated photoproduction of reactive oxygen species for cancer cell annihilation. Photochem Photobiol 86(2):431–437CrossRef
85.
Rakovich A, Savateeva D, Rakovich T, Donegan JF, Rakovich YP et al (2010) Cdte quantum dot/dye hybrid system as photosensitizer for photodynamic therapy. Nanoscale Res Lett 5(4):753–760CrossRef
86.
Choi HS, Liu W, Liu F, Nasr K, Misra P et al (2010) Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 5(1):42–47CrossRef
87.
Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA (2011) Beating cancer in multiple ways using nanogold. Chem Soc Rev 40(7):3391–3404CrossRef
88.
Jain PK, Huang X, El-Sayed IH, El-Sayed MA (2008) Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 41(12):1578–1586CrossRef
89.
Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2(5):681–693CrossRef
90.
Van de Broek B, Devoogdt N, D’Hollander A, Gijs HL, Jans K et al (2011) Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 5(6):4319–4328CrossRef
91.
Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H et al (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (pptt) of squamous cell carcinoma in mice. Cancer Lett 269(1):57–66CrossRef
92.
Lal S, Clare SE, Halas NJ (2008) Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 41(12):1842–1851CrossRef
93.
Fisher JW, Sarkar S, Buchanan CF, Szot CS, Whitney J et al (2010) Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation. Cancer Res 70(23):9855–9864CrossRef
94.
Yang K, Zhang S, Zhang G, Sun X, Lee ST et al (2010) Graphene in mice: Ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 10(9):3318–3323CrossRef
95.
Robinson JT, Tabakman SM, Liang Y, Wang H, Casalongue HS et al (2011) Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 133(17):6825–6831CrossRef
96.
Huang X, Tang S, Mu X, Dai Y, Chen G et al (2011) Freestanding palladium nanosheets with plasmonic and catalytic properties. Nat Nanotechnol 6(1):28–32CrossRef
97.
Hessel CM, Pattani VP, Rasch M, Panthani MG, Koo B et al (2011) Copper selenide nanocrystals for photothermal therapy. Nano Lett 11(6):2560–2566CrossRef
98.
Xie J, Huang J, Li X, Sun S, Chen X (2009) Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 16(10):1278–1294CrossRef
99.
Xie J, Liu G, Eden HS, Ai H, Chen X (2011) Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 44(10):883–892CrossRef
100.
Kievit FM, Zhang M (2011) Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 44(10):853–862CrossRef
101.
Lee J-H, Jang J-T, Choi J-S, Moon SH, Noh S-H et al (2011) Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 6(7):418–422CrossRef
102.
Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW et al (2012) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12(1):39–50CrossRef
103.
Venditto VJ, Szoka FC Jr (2013) Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliv Rev 65(1):80–88CrossRef
Metadaten
Titel
Nanomedicine: Implications from Nanotoxicity
verfasst von
Ruhong Zhou
Copyright-Jahr
2015
Buch
Modeling of Nanotoxicity

Print ISBN: 978-3-319-15381-0

Electronic ISBN: 978-3-319-15382-7

Copyright-Jahr: 2015

DOI
https://doi.org/10.1007/978-3-319-15382-7_9

Neuer Inhalt

    Bildnachweise